Search - tctmd.com

Displaying 41 - 60 of 65

Sort: Relevancy | Date

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Michael O'Riordan

March 28, 2020

News Conference News ACC 2020

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

Michael O'Riordan

March 19, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Daily News

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

Michael O'Riordan

December 10, 2019

News Conference News PCR London Valves 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Daily News

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Michael O'Riordan

August 09, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News ESC 2018

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Michael O'Riordan

March 27, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

Advertisement

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content